SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sigma Labs, Inc. (SASI) .
本页证实的标准:
- VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($2.00, 51.8%).
- 分析师共识目标价 $2.00 (-51.8% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 17/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
10/100
Price-to-Earnings & upside
Proven by this page
✗
健康
17/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SASI
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率17.38
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.45
每股账面价值$0.00
每股营收$0.24
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$2.00 (-51.8%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2015 |
$-108.94 |
$1.23M |
$-1.7M |
-137.4% |
| 2016 |
$-140.60 |
$966.42K |
$-2.2M |
-227.3% |
| 2017 |
$-207.91 |
$641.05K |
$-4.58M |
-714.1% |
| 2018 |
$-161.62 |
$388.57K |
$-5.57M |
-1434.5% |
| 2019 |
$-107.76 |
$402.45K |
$-6.34M |
-1574.8% |
| 2020 |
$-29.12 |
$807.49K |
$-5.58M |
-690.5% |
| 2021 |
$-17.27 |
$1.65M |
$-8.49M |
-513.9% |
| 2022 |
$-16.44 |
$630.43K |
$-8.63M |
-1368.7% |
| 2024 |
$-2.23 |
$501.42K |
$-10.12M |
-2018.3% |
| 2025 |
$-1.45 |
$2.14M |
$-10.69M |
-499.5% |
